Literature DB >> 7013709

Nature of intracellular type A botulinum neurotoxin.

E P Krysinski, H Sugiyama.   

Abstract

The neurotoxin in cells of young Clostridium botulinum type A culture was extracted with lysozyme. Highly purified neurotoxin preparation, obtained by processing the extract in two chromatographic steps had only unnicked (single-chain) molecules of molecular weight comparable to that of the dichains isolated from type A crystals. Trypsinization converted the unnicked molecules into dichains whose component subunits were of sizes indistinguishable from those of the neurotoxin from crystals. The enzymatic treatment increased toxicity of crude extract 30-fold but did not activate the purified intracellular neurotoxin preparation. The results indicated that intracellular type A botulinum neurotoxin is unnicked, is not fully activated, and is activated in the time between its extraction and purification. Since trypsinization nicked all of the single chains without increasing toxicity, nicking was not causally related to toxicity activation.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7013709      PMCID: PMC243758          DOI: 10.1128/aem.41.3.675-678.1981

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  15 in total

1.  Clostridium botulinum type D toxin: purification, molecular structure, and some immunological properties.

Authors:  S Miyazaki; M Iwasaki; G Sakaguchi
Journal:  Infect Immun       Date:  1977-08       Impact factor: 3.441

2.  Molecular forms of neurotoxins in proteolytic Clostridium botulinum type B cultures.

Authors:  B R Dasgupta; H Sugiyama
Journal:  Infect Immun       Date:  1976-09       Impact factor: 3.441

3.  Single chain and dichain forms of neurotoxin in type F Clostridium botulinum culture.

Authors:  B R DasGupta; H Sugiyama
Journal:  Toxicon       Date:  1977       Impact factor: 3.033

4.  Response of type B and E Botulinum toxins to purified sulfhydryl-dependent protease produced by Clostridium botulinum type F.

Authors:  I Ohishi; G Sakaguchi
Journal:  Jpn J Med Sci Biol       Date:  1977-08

5.  Isolation and characterization of a protease from Clostridium botulinum type B.

Authors:  B R Dasgupta; H Sugiyama
Journal:  Biochim Biophys Acta       Date:  1972-06-16

6.  The role of sulfhydryl groups in the activity of type A botulinum toxin.

Authors:  J Knox; W P Brown; L Spero
Journal:  Biochim Biophys Acta       Date:  1970-08-21

7.  A common subunit structure in Clostridium botulinum type A, B and E toxins.

Authors:  B R DasGupta; H Sugiyama
Journal:  Biochem Biophys Res Commun       Date:  1972-07-11       Impact factor: 3.575

8.  Improved procedure for crystallization of Clostridium botulinum type A toxic complexes.

Authors:  H Sugiyama; L J Moberg; S L Messer
Journal:  Appl Environ Microbiol       Date:  1977-04       Impact factor: 4.792

9.  Activation of botulinum toxins in the absence of nicking.

Authors:  I Ohishi; G Sakaguchi
Journal:  Infect Immun       Date:  1977-08       Impact factor: 3.441

10.  Isolation and characterization of an esterase-active enzyme from pronase with special reference to activation of Clostridium botulinum type E progenitor toxin.

Authors:  T Miura
Journal:  Jpn J Med Sci Biol       Date:  1974-12
View more
  3 in total

1.  Botulinum type A neurotoxin digested with pepsin yields 132, 97, 72, 45, 42, and 18 kD fragments.

Authors:  J A Gimenez; B R DasGupta
Journal:  J Protein Chem       Date:  1993-06

2.  Purification and characterization of a protease from Clostridium botulinum type A that nicks single-chain type A botulinum neurotoxin into the di-chain form.

Authors:  M L Dekleva; B R Dasgupta
Journal:  J Bacteriol       Date:  1990-05       Impact factor: 3.490

3.  Regulation of Botulinum Neurotoxin Synthesis and Toxin Complex Formation by Arginine and Glucose in Clostridium botulinum ATCC 3502.

Authors:  Chase M Fredrick; Guangyun Lin; Eric A Johnson
Journal:  Appl Environ Microbiol       Date:  2017-06-16       Impact factor: 4.792

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.